This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Boehringer Ingelheim International Gmbh. Active years: 2023.
Company Filing History:
Years Active: 2023
Title: Walter Carroll Davidson: Innovator in Cancer Treatment Antibody Molecules
Introduction
Walter Carroll Davidson, an esteemed inventor based in Croton, NY, has made significant contributions to the field of medical innovation. With a focus on cancer treatment, he holds a patent that is making waves in therapeutic solutions.
Latest Patents
Davidson's notable patent is for antibody molecules specifically designed for cancer treatment. His invention relates to novel anti-PD1 and anti-LAG3 antibody molecules. It encompasses nucleic acids encoding these antibody molecules, methods for their preparation, and host cells that can express them. Moreover, the patent covers compositions that incorporate these antibody molecules and their therapeutic uses particularly aimed at combating cancer diseases.
Career Highlights
Currently, Walter Carroll Davidson is affiliated with Boehringer Ingelheim International GmbH, a company renowned for its commitment to innovative pharmaceutical solutions. His expertise in antibody engineering contributes tremendously to the development of advanced cancer therapies.
Collaborations
Throughout his career, Davidson has collaborated with an impressive team, including noteworthy colleagues such as Markus Zettl and Ivo Lorenz. These partnerships have played a crucial role in driving forward the research and application of antibody technologies in cancer treatment.
Conclusion
In summary, Walter Carroll Davidson stands out as a pivotal figure in the realm of medical innovations, particularly with his patent for antibody molecules aimed at treating cancer. His work at Boehringer Ingelheim International GmbH and collaborations with talented professionals highlight his commitment to advancing therapeutic approaches in the battle against cancer.